Ovarian Cancer


Consolidation Radiotherapy After Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian Cancer
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Oral contraceptives and the risk of hereditary ovarian cancer
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives. SHARE Study Group. Steroid Hormones and Reproductions

News
CT Scans Can ID Gemcitabine Response in Pancreatic Cancer

Mar 20, 2014 - Transport properties identified on routine computed tomography scans correlate with clinically relevant end points for patients with pancreatic ductal adenocarcinoma who receive preoperative gemcitabine chemoradiotherapy, according to a study published online March 10 in the Journal of Clinical Investigation.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More